Intervention for Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
CancerSurvivorship Care Plan-Personal Health Record (SCP-PHR) - Behavioral
Eligibility
18 - 99
All Sexes
What conditions do you have?
Select

Study Summary

To understand the effectiveness and implementation of the SCP-PHR, we will conduct a hybrid type 1 effectiveness-implementation trial consisting of the following components: (A) a randomized clinical effectiveness trial, and (B) a mixed methods implementation study.

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 12 months

12 months
Colorectal Cancer Surveillance Outcomes
Preventive Care Outcomes
Symptom Measures

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
Intervention
1 of 2

Active Control

Experimental Treatment

250 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · No Placebo Group · N/A

Intervention
Behavioral
Experimental Group · 1 Intervention: Survivorship Care Plan-Personal Health Record (SCP-PHR) · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Indiana UniversityLead Sponsor
876 Previous Clinical Trials
749,326 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,071 Previous Clinical Trials
41,128,605 Total Patients Enrolled
David A Haggstrom, MDPrincipal InvestigatorIndiana University School of Medicine
1 Previous Clinical Trials
57,073 Total Patients Enrolled

Eligibility Criteria

Age 18 - 99 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be 18 years or older to consent to this study.
You must have regular (at least weekly) access to an internet connection.
You have colon or rectal cancer and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months.